Two Sigma Advisers’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Two Sigma Advisers’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-10,012	Closed	-$241K	–	2944
2014 Q2	$241K	Buy	+10,012	New	+$104K	﹤0.01%	2160

Two Sigma Advisers's IDIX Position: Q3 2014 in Review

Two Sigma Advisers sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 10,012 shares — an estimated $241K sold.

Two Sigma Advisers first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $241K in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Two Sigma Advisers reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Two Sigma Advisers sold 10,012 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $241K.
Two Sigma Advisers first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
Two Sigma Advisers's IDENIX PHARMACEUTICALS INC position peaked at $241K in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Two Sigma Advisers's 13F filing for Q3 2014, filed 14 Nov 2014.